Telik (TELK) Move "Very Silly" - Feuerstein
Tweet
Share
E-mailGet Alerts TELK Hot Sheet
Join SI Premium – FREE
Biotech watcher Adam Feuerstein said "very silly" for Telik Inc. (NASDAQ: TELK) to be up 60% on orphan drug designation.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AGBA Group Holding (AGBA) selling off into close, down over 17%
- BofA says there is a continued strength in buybacks
- UK CMA Seeks Views on Microsoft and Amazon's AI Partnerships - Bloomberg
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
